[Federal Register Volume 85, Number 132 (Thursday, July 9, 2020)]
[Notices]
[Page 41244]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-14781]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-674]


Bulk Manufacturer of Controlled Substances Application: Purisys, 
LLC

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may file written comments on or objections to 
the issuance of the proposed registration on or before September 8, 
2020.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this 
is notice that on May 14, 2020, Purisys, LLC, 1550 Olympic Drive 
Athens, Georgia 30601-1602, applied to be registered as a bulk 
manufacturer of the following basic class(es) of controlled substances:

------------------------------------------------------------------------
                                           Drug
          Controlled substance             code          Schedule
------------------------------------------------------------------------
Gamma-hydroxybutyic acid................    2010  I
Marihuana Extract.......................    7350  I
Marihuana...............................    7360  I
Tetrahydrocannabinols...................    7370  I
Codeine-N-Oxide.........................    9053  I
Dihydromorphine.........................    9145  I
Hydromorphinol..........................    9301  I
Nabilone................................    7379  II
Codeine.................................    9050  II
Dihydrocodeine..........................    9120  II
Oxycodone...............................    9143  II
Hydromorphone...........................    9150  II
Hydrocodone.............................    9193  II
Levorphanol.............................    9220  II
Morphine................................    9300  II
------------------------------------------------------------------------

    The company plans to manufacture 7360, 7370, and 7379 as bulk 
active pharmaceutical ingredients and manufacture the remaining above-
listed controlled substances as analytical reference standards for 
distribution to customers. The company also plans to use these 
substances for lab scale research and development activities. In 
reference to drug codes 7360 and 7370, the company plans to bulk 
manufacture these as synthetic. No other activities for these drug 
codes are authorized for this registration.

William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-14781 Filed 7-8-20; 8:45 am]
BILLING CODE P